These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 1292247

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Captopril, an angiotensin I-converting enzyme inhibitor, decreases proteinuria in hypertensive patients with renal diseases.
    Ikeda T, Nakayama D, Gomi T, Sakurai J, Yamazaki T, Yuhara M.
    Nephron; 1989; 52(1):72-5. PubMed ID: 2651951
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [The effect of blood pressure-reducing therapy with captopril on tubular marker excretion in type-1 diabetics with nephropathy].
    Ratzmann KP, Raskovic M, Schimke E.
    Dtsch Med Wochenschr; 1994 Jun 03; 119(22):796-800. PubMed ID: 8205941
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Comparison of the effect of pentoxifylline and captopril on proteinuria in patients with type 2 diabetes mellitus.
    Aminorroaya A, Janghorbani M, Rezvanian H, Aminian T, Gharavi M, Amini M.
    Nephron Clin Pract; 2005 Jun 03; 99(3):c73-7. PubMed ID: 15665549
    [Abstract] [Full Text] [Related]

  • 34. Enalapril can treat the proteinuria of membranous glomerulonephritis without detriment to systemic or renal hemodynamics.
    Thomas DM, Hillis AN, Coles GA, Davies M, Williams JD.
    Am J Kidney Dis; 1991 Jul 03; 18(1):38-43. PubMed ID: 1712151
    [Abstract] [Full Text] [Related]

  • 35. Clinical effect of dipyridamole in patients with IgA nephropathy.
    Yagame M, Tomino Y, Miura M, Suga T, Endoh M, Nomoto Y, Sakai H.
    Tokai J Exp Clin Med; 1986 Nov 03; 11(5):329-33. PubMed ID: 2960035
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. ACE inhibition reduces proteinuria in normotensive patients with IgA nephropathy: a multicentre, randomized, placebo-controlled study.
    Maschio G, Cagnoli L, Claroni F, Fusaroli M, Rugiu C, Sanna G, Sasdelli M, Zuccalà A, Zucchelli P.
    Nephrol Dial Transplant; 1994 Nov 03; 9(3):265-9. PubMed ID: 8052432
    [Abstract] [Full Text] [Related]

  • 38. Renal targeting of captopril using captopril-lysozyme conjugate enhances its antiproteinuric effect in adriamycin-induced nephrosis.
    Windt WA, Prakash J, Kok RJ, Moolenaar F, Kluppel CA, de Zeeuw D, van Dokkum RP, Henning RH.
    J Renin Angiotensin Aldosterone Syst; 2004 Dec 03; 5(4):197-202. PubMed ID: 15803438
    [Abstract] [Full Text] [Related]

  • 39. Cyclosporin treatment of IgA nephropathy: a short term controlled trial.
    Lai KN, Lai FM, Li PK, Vallance-Owen J.
    Br Med J (Clin Res Ed); 1987 Nov 07; 295(6607):1165-8. PubMed ID: 3120928
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.